Effect of the


Journal

Parasitology
ISSN: 1469-8161
Titre abrégé: Parasitology
Pays: England
ID NLM: 0401121

Informations de publication

Date de publication:
09 2020
Historique:
pubmed: 30 5 2020
medline: 10 4 2021
entrez: 30 5 2020
Statut: ppublish

Résumé

Trypanosoma cruzi, the etiological agent of Chagas disease, releases factors, including antigens from the trans-sialidase (TS) superfamily, which modulate the host immune responses. Tc13 antigens belong to group IV of TSs and are characterized by C-terminal EPKSA repeats. Here, we studied the effect of the Tc13 antigen from the Tulahuén strain, Tc13Tul, on primary cultures of splenocytes from naïve BALB/c mice. Recombinant Tc13Tul increased the percentage of viable cells and induced B (CD19+) lymphocyte proliferation. Tc13Tul stimulation also induced secretion of non-specific IgM and interferon-γ (IFN-γ). The same effects were induced by Tc13Tul on splenocytes from naïve C3H/HeJ mice. In vivo administration of Tc13Tul to naïve BALB/c mice increased non-specific IgG in sera. In addition, in vitro cultured splenocytes from Tc13Tul-inoculated mice secreted a higher basal level of non-specific IgM than controls and the in vitro Tc13Tul stimulation of these cells showed an enhanced effect on IgM and IFN-γ secretion. Our results indicate that Tc13Tul may participate in the early immunity in T. cruzi infection by favouring immune system evasion through B-cell activation and non-specific Ig secretion. In contrast, as IFN-γ is an important factor involved in T. cruzi resistance, this may be considered a Tc13Tul effect in favour of the host.

Identifiants

pubmed: 32466805
doi: 10.1017/S0031182020000864
pii: S0031182020000864
pmc: PMC10317719
doi:

Substances chimiques

Antigens, Protozoan 0
Glycoproteins 0
Immunoglobulin G 0
Recombinant Proteins 0
trans-sialidase EC 3.2.1.-
Neuraminidase EC 3.2.1.18

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1114-1123

Références

Infect Immun. 1999 Aug;67(8):3864-71
pubmed: 10417150
Exp Parasitol. 2003 Mar-Apr;103(3-4):112-9
pubmed: 12880587
Parasitology. 2006 Jun;132(Pt 6):855-66
pubmed: 16478565
PLoS One. 2013;8(2):e57450
pubmed: 23437390
J Infect Dis. 1999 Oct;180(4):1398-402
pubmed: 10479182
Parasitology. 2008 Mar;135(3):347-57
pubmed: 17991305
PLoS Negl Trop Dis. 2010 Jul 06;4(7):e733
pubmed: 20625554
J Clin Microbiol. 1994 Apr;32(4):971-4
pubmed: 8027352
Immunology. 2011 Jan;132(1):123-33
pubmed: 20875075
J Infect Dis. 1998 Feb;177(2):431-6
pubmed: 9466532
Mol Cell. 2002 Oct;10(4):757-68
pubmed: 12419220
Nat Med. 2000 Aug;6(8):890-7
pubmed: 10932226
Infect Immun. 2014 Sep;82(9):3687-96
pubmed: 24935974
Cell Microbiol. 2006 Jul;8(7):1086-95
pubmed: 16819962
J Immunol. 2002 May 15;168(10):5192-8
pubmed: 11994475
J Leukoc Biol. 2019 May;105(5):843-856
pubmed: 30457676
Int Immunol. 2002 Mar;14(3):299-308
pubmed: 11867566
Cell Res. 2014 Feb;24(2):161-76
pubmed: 24296781
Immunology. 1998 Jun;94(2):189-96
pubmed: 9741340
FEMS Microbiol Lett. 2000 Aug 15;189(2):253-7
pubmed: 10930747
Gene. 1995 Jul 4;160(1):123-8
pubmed: 7628705
PLoS Pathog. 2006 Aug;2(8):e77
pubmed: 16879036
PLoS One. 2013;8(3):e58967
pubmed: 23536842
Trends Parasitol. 2017 Feb;33(2):102-112
pubmed: 27843019
PLoS Pathog. 2010 Apr 29;6(4):e1000870
pubmed: 20442858
Lancet. 2010 Apr 17;375(9723):1388-402
pubmed: 20399979
Infect Immun. 1996 Jan;64(1):128-34
pubmed: 8557330
Glycobiology. 1999 Jun;9(6):581-7
pubmed: 10336990
Eur J Immunol. 1992 Oct;22(10):2501-6
pubmed: 1396957
J Immunol. 2000 Aug 1;165(3):1331-6
pubmed: 10903734
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43
pubmed: 25671846
J Immunol. 1999 May 15;162(10):6092-9
pubmed: 10229851
Infect Immun. 2005 Jan;73(1):181-92
pubmed: 15618153
Cancer Res. 1960 May;20:462-6
pubmed: 14427849
Cell. 2006 Feb 24;124(4):783-801
pubmed: 16497588
Diagn Microbiol Infect Dis. 2013 Jun;76(2):197-205
pubmed: 23537784
Scand J Immunol. 1988 Nov;28(5):553-61
pubmed: 2463663
Int Immunopharmacol. 2017 Sep;50:338-344
pubmed: 28750349
Mol Biochem Parasitol. 1989 May 15;34(3):221-8
pubmed: 2499788
J Immunol. 1994 Oct 1;153(7):3148-54
pubmed: 7522250
Indian J Crit Care Med. 2009 Apr-Jun;13(2):49-53
pubmed: 19881183
Parasitol Today. 1992 Nov;8(11):378-81
pubmed: 15463546
Blood. 1999 Mar 15;93(6):2025-32
pubmed: 10068675
J Immunol. 1992 Dec 1;149(11):3753-8
pubmed: 1385530
J Control Release. 2016 Oct 10;239:107-17
pubmed: 27574990
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1239-43
pubmed: 1371355
J Immunol. 2002 Jun 15;168(12):6366-74
pubmed: 12055254
Infect Immun. 2008 Feb;76(2):750-8
pubmed: 18070905
PLoS One. 2011;6(10):e25914
pubmed: 22039427
Infect Immun. 2001 Dec;69(12):7946-9
pubmed: 11705983
Glycobiology. 2004 Nov;14(11):53R-62R
pubmed: 15229195
Front Immunol. 2016 Jan 18;6:659
pubmed: 26834737
Immunity. 2001 May;14(5):617-29
pubmed: 11371363
Science. 1998 Dec 11;282(5396):2085-8
pubmed: 9851930
J Exp Med. 1978 Jun 1;147(6):1744-54
pubmed: 308089
Nat Immunol. 2013 May;14(5):514-22
pubmed: 23563688
J Biol Chem. 2004 Feb 13;279(7):5323-8
pubmed: 14634017
J Biol Chem. 2002 Nov 29;277(48):45962-8
pubmed: 12237289

Auteurs

Laura Mónica Tasso (LM)

Instituto Nacional de Parasitología (INP) 'Dr. Mario Fatala Chaben'-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina.

Andrea Cecilia Bruballa (AC)

Instituto Nacional de Parasitología (INP) 'Dr. Mario Fatala Chaben'-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina.

Patricia Andrea Garavaglia (PA)

Instituto Nacional de Parasitología (INP) 'Dr. Mario Fatala Chaben'-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina.

Mónica Inés Esteva (MI)

Instituto Nacional de Parasitología (INP) 'Dr. Mario Fatala Chaben'-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina.

María Cecilia Albareda (MC)

Instituto Nacional de Parasitología (INP) 'Dr. Mario Fatala Chaben'-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina.

Gabriela Andrea García (GA)

Instituto Nacional de Parasitología (INP) 'Dr. Mario Fatala Chaben'-ANLIS 'Dr. Carlos G. Malbrán', Buenos Aires, Argentina.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH